Products
Pharmaceuticals
Pharmaceuticals
No. Product Name CAS No. Application Structural Formula
81 3-benzyl-6-bromo-2-methoxyquinoline 654655-69-3 Bedaquiline Intermediates 3-benzyl-6-bromo-2-methoxyquinoline
82 3,3,20,20-Bis-ethylendioxy-9β,10α-pregna-5,7-dien 5488-51-7 Dydrogesterone Intermediates 3,3,20,20-Bis-ethylendioxy-9β,10α-pregna-5,7-dien
83 4-Amino-2-hydroxy-5-methylpyridine 95306-64-2 Finerenone Intermediates 4-Amino-2-hydroxy-5-methylpyridine
84 2-Nitro-1,4-phenylenediamine 5307-14-2 Retigabine Intermediates 2-Nitro-1,4-phenylenediamine
85 6-Methyl-2-(p-tolyl)imidazo[1,2-a]pyridine 88965-00-8 Zolpidem Intermediates 6-Methyl-2-(p-tolyl)imidazo[1,2-a]pyridine
86 7-Hydroxyquinolinone 70500-72-0 Brexpiprazole Intermediates 7-Hydroxyquinolinone
87 (R)-2-Methoxypropanoic acid 23943-96-6 Intermediates (R)-2-Methoxypropanoic acid
88 (S)-(-)-2-Methoxypropionic acid 23953-00-6 Intermediates (S)-(-)-2-Methoxypropionic acid
89 Methyl (2R)-2-methoxypropanoate 54656-63-2 Intermediates Methyl (2R)-2-methoxypropanoate
90 (S)-Methyl 2-methoxypropanoate 54656-65-4 Intermediates (S)-Methyl 2-methoxypropanoate
91 Ethyl 6-Hydroxyhexanoate 5299-60-5 Intermediates Ethyl 6-Hydroxyhexanoate
92 Methyl 6-hydroxyhexanoate 4547-43-7 Intermediates Methyl 6-hydroxyhexanoate
93 5-(Benzyloxy)-5-oxopentanoic acid 54322-10-0 Intermediates 5-(Benzyloxy)-5-oxopentanoic acid
94 4-Bromo-1-methylpyrazole 15803-02-8 Intermediates 4-Bromo-1-methylpyrazole
95 1,3-dimethylpyrazole-4-carbaldehyde 25016-12-0 Intermediates 1,3-dimethylpyrazole-4-carbaldehyde
96 Azetidine dihydrochloride 78797-58-7 Intermediates Azetidine dihydrochloride
97 (2S)-azetidine-2-carboxamide hydrochloride 648907-88-4 Intermediates (2S)-azetidine-2-carboxamide hydrochloride
98 2,4-Diamino-5-methylpyridine 1033203-34-7 Intermediates 2,4-Diamino-5-methylpyridine
99 4-Amino-2,6-dichloropyridine 2587-02-2 Intermediates 4-Amino-2,6-dichloropyridine
100 4-Amino-2,6-dichloro-3-nitropyridine 2897-43-0 Intermediates 4-Amino-2,6-dichloro-3-nitropyridine
147 Records First 34567 8
Follow us